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A 54-year-old depressive woman was admitted to the 
emergency department with a Glasgow Coma Scale of six 
(E1V1M4) and hypothermia (34°C). A drug overdose was 
early suspected by history as the patient was treated by 
tricyclic antidepressants (TCA). The maximal ingested dose 
was 1000 mg for amitriptyline and 8400 mg for clomipramine, 
and the delay from ingestion was unknown. The admission 
serum concentration was 56.2 ng/ml (therapeutic, 50-200) 
for amitriptyline, 1117.7 ng/ml (150-300) for clomipramine 
and 628.9 ng/ml (150-300) for desclomipramine. The 
electrocardiogram showed sinus rhythm (77/min), with 
normal QRS duration and a QTc interval at 480 msec. The 
hemodynamic condition was stable with an arterial blood 
pressure of 141/57 mmHg. Treatment included mechanical 
ventilation in the intensive care unit and passive rewarming. 
Extubation was possible 12 hours after admission, and the 
patient did not experience any serious cardiac manifestations. 
However, she developed anticholinergic encephalopathy with 
confusion, agitation, dysarthria, dilated pupils, dry and flushed 
skin, but no fever. The most striking clinical finding was 
uncontrolled movements in both legs (Video), and to a lesser 
extent, in arms and face. Some improvement was noted after 
benzodiazepines administration and a complete resolution was 
observed after two days.
Akathisia is a movement disorder frequently associated 
with the use of antipsychotic drugs that are dopamine-receptor 
D2 antagonists. Akathisia usually consists of two components, 
subjective restlessness and typical movements such as 
shuffling of the legs, pacing, shifting weight from one leg to 
the other, and rocking movements of the trunk. Akathisia as 
extrapyramidal symptom is seldom reported after therapeutic 
doses or overdoses of TCA.¹ The theoretical mechanism of the 
anticholinergic-induced dyskinesias is not clear and should 
result from a relative dopaminergic-cholinergic imbalance 
in the basal ganglia. In this condition, treatment with 
benzodiazepines is safer than with physostigmine.² 
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